Kura Oncology, Inc. (KURA)
8.805
+0.24
(+2.86%)
USD |
NASDAQ |
Jun 09, 16:00
8.805
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology SG&A Expense (Quarterly) : 31.56M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 11.45M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Exelixis, Inc. | 139.60M |
| Gilead Sciences, Inc. | 1.451B |
| Capricor Therapeutics, Inc. | 9.396M |